fig2
![Clinical and therapeutic implications of melanoma genomics](https://image.oaes.cc/9d533686-76f9-444a-b80d-cc8fa07cb663/2813.fig.2.png)
Figure 2. Selected driver mutations in melanoma broken down by non-acral cutaneous melanoma genomic subclass (BRAF, RAS, NF1, and triple-wild type) and melanoma subtype (acral, mucosal, cutaneous). Adapted with permission from Hayward et al.[46]